Inovio Pharmaceuticals, Inc. (INO)
1.155
-0.04
(-2.94%)
USD |
NASDAQ |
Apr 16, 16:00
1.17
+0.02
(+1.30%)
After-Hours: 18:27
Inovio Pharmaceuticals Research and Development Expense (Quarterly) : 9.921M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.807M |
| ADMA Biologics, Inc. | 1.376M |
| Vaxart, Inc. | 45.15M |
| Capricor Therapeutics, Inc. | 22.88M |
| Allogene Therapeutics, Inc. | 25.58M |